Use of mTOR inhibitors in the treatment of malignancies

Author： Mohindra Nisha A Giles Francis J Platanias Leonidas C

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.7, 2014-05, pp. : 979-990

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

mTOR inhibitors in the treatment of cancer

By Fasolo Angelica Sessa Cristiana

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1717-1734

Informa Healthcare

Access to resources Recommend Favorite

The promise of mTOR inhibitors in the treatment of colorectal cancer

By Kim Dae-Dong Eng Cathy

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1775-1788

Informa Healthcare

Access to resources Recommend Favorite

Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC

Current Medicinal Chemistry, Vol. 23, Iss. 37, 2016-12 ,pp. : 4260-4269

Bentham Science Publishers

Access to resources Recommend Favorite

The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma

By Ponziani Francesca Ojetti Veronica Tortora Annalisa Di Maurizio Luca Purchiaroni Flaminia Gasbarrini Antonio

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1535-1546

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 121-125

Bentham Science Publishers

Access to resources Recommend Favorite